C K Varley

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Sudden death of a child treated with imipramine. Case study
    C K Varley
    Division of Child and Adolescent Psychiatry, University of Washington, Seattle 98105, USA
    J Child Adolesc Psychopharmacol 10:321-5. 2000
  2. ncbi request reprint Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications
    C K Varley
    Division of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA
    Paediatr Drugs 3:613-27. 2001
  3. ncbi request reprint Anxiety disorders in the child and teen
    Christopher K Varley
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98177, USA
    Pediatr Clin North Am 50:1107-38. 2003
  4. ncbi request reprint A survey of the interactions between psychiatry residency programs and the pharmaceutical industry
    Christopher K Varley
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Box 359300 CL 08, Seattle, WA 98195, USA
    Acad Psychiatry 29:40-6. 2005
  5. ncbi request reprint Treating depression in children and adolescents: what options now?
    Christopher K Varley
    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA
    CNS Drugs 20:1-13. 2006
  6. ncbi request reprint Commentary by an academic child psychiatrist on the relationship of the pharmaceutical industry, academia, psychiatric practice, and the Food and Drug Administration
    Christopher K Varley
    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, and Department of Psychiatry and Behavioral Medicine, Children s Hospital and Regional Medical Center, Seattle 98105, USA
    J Child Adolesc Psychopharmacol 17:292-4. 2007
  7. ncbi request reprint Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications
    C K Varley
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA
    Compr Psychiatry 42:228-33. 2001
  8. ncbi request reprint Psychopharmacological treatment of major depressive disorder in children and adolescents
    Christopher K Varley
    JAMA 290:1091-3. 2003

Detail Information

Publications8

  1. ncbi request reprint Sudden death of a child treated with imipramine. Case study
    C K Varley
    Division of Child and Adolescent Psychiatry, University of Washington, Seattle 98105, USA
    J Child Adolesc Psychopharmacol 10:321-5. 2000
    ..Prior to death, there were signs of possible cardiovascular abnormalities after treatment was begun with imipramine. The report adds to the concern over the use of tricyclics in children...
  2. ncbi request reprint Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications
    C K Varley
    Division of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA
    Paediatr Drugs 3:613-27. 2001
    ..This protocol needs to be validated with regard to utility and the degree of assistance it provides in the management of children treated with TCAs...
  3. ncbi request reprint Anxiety disorders in the child and teen
    Christopher K Varley
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98177, USA
    Pediatr Clin North Am 50:1107-38. 2003
    ..There is a need for teamwork and effective communication among team members in addressing pediatric and adolescent anxiety disorders...
  4. ncbi request reprint A survey of the interactions between psychiatry residency programs and the pharmaceutical industry
    Christopher K Varley
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Box 359300 CL 08, Seattle, WA 98195, USA
    Acad Psychiatry 29:40-6. 2005
    ..The authors report a survey of the American Association of Directors of Psychiatry Residency Training (AADPRT) on interactions between the pharmaceutical industry and psychiatry residency programs...
  5. ncbi request reprint Treating depression in children and adolescents: what options now?
    Christopher K Varley
    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA
    CNS Drugs 20:1-13. 2006
    ..On balance, there appears to be evidence of the benefit for antidepressant medications in children and adolescents, which outweigh safety concerns...
  6. ncbi request reprint Commentary by an academic child psychiatrist on the relationship of the pharmaceutical industry, academia, psychiatric practice, and the Food and Drug Administration
    Christopher K Varley
    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, and Department of Psychiatry and Behavioral Medicine, Children s Hospital and Regional Medical Center, Seattle 98105, USA
    J Child Adolesc Psychopharmacol 17:292-4. 2007
  7. ncbi request reprint Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications
    C K Varley
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA
    Compr Psychiatry 42:228-33. 2001
    ..Controversy remains as to the long-term risk of tics in relation to stimulant medication and to appropriate practice should tics emerge during the course of stimulant medication treatment...
  8. ncbi request reprint Psychopharmacological treatment of major depressive disorder in children and adolescents
    Christopher K Varley
    JAMA 290:1091-3. 2003